Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 5, 2010, Pages 787-793

  Watanabe, Shin Ichi ^a   Miyata, Yasuyoshi ^a   Kanda, Shigeru ^b   Iwata, Takahisa ^a   Hayashi, Tomayoshi ^c   Kanetake, Hiroshi ^a   Sakai, Hideki ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization Nagasaki Hospital   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; Caspase 3; Neo adjuvant hormonal therapy; Prostate cancer; X linked inhibitor of apoptosis

Indexed keywords

ANTIANDROGEN; CASPASE 3; GONADORELIN AGONIST; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; ADJUVANT THERAPY; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSTATE TUMOR;

AGED; ANDROGEN ANTAGONISTS; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSTATECTOMY; PROSTATIC NEOPLASMS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 77950482756     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0718-x     Document Type: Article

References (30)

1. Aus G, Abrahamsson P-A, Ahlgren G, Hugosson J, Lundberg S, Schain M (2002) Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial. BJU Int 90:561-566
2. Borner C, Monney L (1999) Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ 6:497-507
3. D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW (2004) 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 292:821-827
4. Davison FD, Groves M, Scaravilli F (1995) The effects of formalin fixation on the detection of apoptosis in human brain by in situ end-labeling of DNA. Histochem J 27:983-988
5. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srininvasula SM et al (1998) IAPs block apoptotic event induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215-2223
6. Gleave ME, Goldenberg L, Chin JL, Warner J, Saad F, Klotz LH et al (2001) Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. J Urol 166:2208-2215
7. Golbano JM, Lóppez-Aparicio P, Recio MN, Pérez-Albarsanz MA (2008) Finasteride induces apoptosis via Bcl-2, Bcl-xL and caspase-3 proteins in LNCaP human prostate cancer cell line. Int J Oncol 32:919-924
8. Gu X, Song X, Dong Y, Cai H, Walters E, Zhang R et al (2008) Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 14:1840-1848
9. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP et al (2008) EAU guideline on prostate cancer. Eur Urol 53:68-80
10. Hunter AM, LaCasse EC, Korneluk RG (2007) The inhibitor of apoptosis (IAPs) as cancer targets. Apoptosis 12:1543-1568
11. Karamitopoulou E, Cioccari L, Jacob S, Vallan C, Schaffner T, Zimmermann A et al (2007) Active caspase-3 and DNA fragmentation as markers of apoptotic cell death in primary and metastatic liver tumours. Pathology 39:558-564
12. Krajewska M, Krajewska S, Banares S, Huang X, Turner B, Bubendorf L et al (2003) Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 15:4914-4925
13. Krajewska M, Kim H, Kim C, Kang H, Welsh K, Matsuzawa S et al (2005) Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res 11:5451-5461
14. Kyprianou N, English HF, Issacs JT (1990) Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50:3748-3753
15. LaCasse EC, Cherton-Horvat GG, Jerome L, Morris SJ, Kandimalla ER et al (2006) Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting Xlinked inhibitor of apoptosis. Clin Cancer Res 12:5231-5241
16. Laitinen S, Martikainen PM, Tammela TLJ, Visakorpi T (2007) Cellular changes in prostate cancer cells induced by intermittent androgen suppression. Eur Urol 52:725-732
17. McEleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM (2002) Inhibitors of apoptosis proteins in proteins in prostate cancer cell lines. Prostate 51:133-140
18. McManus DC, Lefebvre CA, Cherton-Horvat G, St-Jean M, Kandimalla ER, Agrawal S et al (2004) Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 23:8105-8117
19. Miyata Y, Kanda S, Sakai H, Hakariya T, Kanetake H (2005) Relationship between changes in prostate cancer cell proliferation, apoptotic index, and apoptosis-related proteins by neoadjuvant hormonal therapy and duration of such therapy. Urology 65:1238-1243
20. Moul JW (2000) Prostate specific antigen only progression of prostate cancer. J Urol 163:1632-1642
21. Omezzine A, Mauduit C, Tabone E, Nabli N, Bouslama A, Benahmed M (2003) Caspase-3 and -6 expression and activation are targeted by hormone action in rat ventral prostate during the apoptotic cell death process. Biol Reprod 69:752-760 (Pubitemid 37064603)
22. Ramp U, Kreig T, Caliskan E, Mahotka C, Ebert T, Willers R et al (2004) XIAP expression is an independent prognostic marker in clear-cell renal carcinomas. Hum Pathol 35:1022-1028
23. Rupinder SK, Gurpreet AK, Manjeet S (2007) Cell suicide and caspases. Vasc Pharmacol 46:383-393
24. Schmidt LJ, Ballman KV, Tindall DJ (2007) Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride. Prostate 67:1111-1120
25. Sohn JH, Kim DH, Choi NG, Park YE, Ro JY (2000) Caspase-3/CPR32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias. Histopathology 37:555-560
26. SolowayMS, Pareek K, Sharifi R, Wajsman Z,McLeod D,Wood DP Jr et al (2002) Neoadjuvant androgen ablation before radical prostatectomy incT2bNxM0 prostate cancer: a 5-year results. J Urol 167:112-116
27. St John Floyd M Jr, TeahanSJ, Fitzpatrick JM, Watson RW (2009) Differential mechanism of bicalutamide-induced apoptosis in prostate cell lines. Prostate Cancer Prostatic Dis 12:25-33
28. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL (1996) Cloning and expression of apoptosis inhibitory protein homologues that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93:4974-4978
29. Watson RB, Civantos F, Soloway MS (1996) Positive surgical margins with radical prostatectomy, detailed pathological analysis and prognosis. Urology 48:80-90
30. Winter RN, Kramer A, Borkowski A, Kyprianou N (2001) Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 61:1227-1232